Adaptation and validation of simple tools to screen and monitor for oral PrEP adherence
Oral, vaginal and other pre-exposure prophylaxis (PrEP) products for HIV prevention are in various stages of development. Low adherence poses a serious challenge to successful evaluation in trials. In a previous study, we developed tools to screen for general adherence and specifically monitor intra...
Gespeichert in:
| Veröffentlicht in: | PloS one 2021-05, Vol.16 (5), p.e0251823-e0251823 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e0251823 |
|---|---|
| container_issue | 5 |
| container_start_page | e0251823 |
| container_title | PloS one |
| container_volume | 16 |
| creator | Zissette, Seth Tolley, Elizabeth E Martinez, Andres Hanif, Homaira Gill, Katherine Mugo, Nelly Myers, Laura Casmir, Ednar Duyver, Menna Ngure, Kenneth Doncel, Gustavo F |
| description | Oral, vaginal and other pre-exposure prophylaxis (PrEP) products for HIV prevention are in various stages of development. Low adherence poses a serious challenge to successful evaluation in trials. In a previous study, we developed tools to screen for general adherence and specifically monitor intravaginal ring adherence within the context of HIV prevention clinical trials. This study aimed to further validate the screening tool and to adapt and provide initial psychometric validation for an oral pill monitoring tool. We administered a cross-sectional survey between June and October 2018 at a trial site located near Cape Town, South Africa, and another in Thika, Kenya, with 193 women who had experience using daily oral pills. We fit confirmatory factor analysis models on the screening tool items to assess our previously-hypothesized subscale structure. We conducted an exploratory factor analysis of oral PrEP monitoring items to determine the underlying subscale structure. We then assessed the construct validity of each tool by comparing subscales against each other within the current sample and against our original sample, from a study conducted in four sites in South Africa, including Cape Town. The screening tool structure showed moderate evidence of construct validity. As a whole, the tool performed in a similar way to the original sample. The monitoring tool items, which were revised to assess perceptions about and experiences using daily oral PrEP, factored into five subscales that showed moderate to good reliability. Four of the five subscales had a similar structure overall to the vaginal ring monitoring tool from which they were adapted. Accurate measurement of HIV-prevention product adherence is of critical importance to the assessment of product efficacy and safety in clinical trials, and the support of safe and effective product use in non-trial settings. In this study, we provide further validation for these measures, demonstrating the screening tool's utility in additional populations and adapting the monitoring tool's utility for different HIV-prevention products. |
| doi_str_mv | 10.1371/journal.pone.0251823 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2533254304</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A663279416</galeid><doaj_id>oai_doaj_org_article_b2d902d873f147d580fad67ae332ba2f</doaj_id><sourcerecordid>A663279416</sourcerecordid><originalsourceid>FETCH-LOGICAL-c618t-8e9bfb7208eb0133d449b56d0acb6725e30e0e5b88190e59c3303f3a3754f9ff3</originalsourceid><addsrcrecordid>eNqNkl-L1DAUxYso7jr6DQQLgujDjElum6YvwrCsOrCwi38fQ9rczGRJmzFpF_32ZnaqbGUfpLRpkl_OzbmcLHtOyYpCRd9e-zH0yq32vscVYSUVDB5kp7QGtuSMwMM7_yfZkxivCSlBcP44O4GCFMDL6jT7vtZqP6jB-j5Xvc5vlLP6OPUmj7bbO8wH711M3zy2AfEIdr63gw-5Sa8PyuVX4fwqV3qHAfsWn2aPjHIRn03jIvv6_vzL2cflxeWHzdn6YtlyKoalwLoxTcWIwIZQAF0UdVNyTVTb8IqVCAQJlo0QtE5j3QIQMKCgKgtTGwOL7MVRd-98lFNPomQlACsLSDYX2eZIaK-u5T7YToVf0isrbxd82EoVBts6lA3TNWFaVGBoUelSEKM0rxQmsUaxQ7V3U7Wx6VC32A_J-kx0vtPbndz6GyloKeq6TgKvJ4Hgf4wYB9nZ2KJzqkc_3t674BREcrnIXv6D3u9uorYqGbC98aluexCVa86BVXVBeaJW91Dp0djZNgXI2LQ-O_BmdiAxA_4ctmqMUW4-f_p_9vLbnH11h92hcsMuejceAhfnYHEE2-BjDGj-NpkSecj_n27IQ_7llH_4Dc6S9UE</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2533254304</pqid></control><display><type>article</type><title>Adaptation and validation of simple tools to screen and monitor for oral PrEP adherence</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>Zissette, Seth ; Tolley, Elizabeth E ; Martinez, Andres ; Hanif, Homaira ; Gill, Katherine ; Mugo, Nelly ; Myers, Laura ; Casmir, Ednar ; Duyver, Menna ; Ngure, Kenneth ; Doncel, Gustavo F</creator><creatorcontrib>Zissette, Seth ; Tolley, Elizabeth E ; Martinez, Andres ; Hanif, Homaira ; Gill, Katherine ; Mugo, Nelly ; Myers, Laura ; Casmir, Ednar ; Duyver, Menna ; Ngure, Kenneth ; Doncel, Gustavo F</creatorcontrib><description>Oral, vaginal and other pre-exposure prophylaxis (PrEP) products for HIV prevention are in various stages of development. Low adherence poses a serious challenge to successful evaluation in trials. In a previous study, we developed tools to screen for general adherence and specifically monitor intravaginal ring adherence within the context of HIV prevention clinical trials. This study aimed to further validate the screening tool and to adapt and provide initial psychometric validation for an oral pill monitoring tool. We administered a cross-sectional survey between June and October 2018 at a trial site located near Cape Town, South Africa, and another in Thika, Kenya, with 193 women who had experience using daily oral pills. We fit confirmatory factor analysis models on the screening tool items to assess our previously-hypothesized subscale structure. We conducted an exploratory factor analysis of oral PrEP monitoring items to determine the underlying subscale structure. We then assessed the construct validity of each tool by comparing subscales against each other within the current sample and against our original sample, from a study conducted in four sites in South Africa, including Cape Town. The screening tool structure showed moderate evidence of construct validity. As a whole, the tool performed in a similar way to the original sample. The monitoring tool items, which were revised to assess perceptions about and experiences using daily oral PrEP, factored into five subscales that showed moderate to good reliability. Four of the five subscales had a similar structure overall to the vaginal ring monitoring tool from which they were adapted. Accurate measurement of HIV-prevention product adherence is of critical importance to the assessment of product efficacy and safety in clinical trials, and the support of safe and effective product use in non-trial settings. In this study, we provide further validation for these measures, demonstrating the screening tool's utility in additional populations and adapting the monitoring tool's utility for different HIV-prevention products.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0251823</identifier><identifier>PMID: 34043657</identifier><language>eng</language><publisher>San Francisco: Public Library of Science</publisher><subject>Acquired immune deficiency syndrome ; Agricultural technology ; Agriculture ; AIDS ; Biology and Life Sciences ; Biomarkers ; Clinical trials ; Cognitive ability ; Dental prophylaxis ; Disease prevention ; Drafting software ; Drug dosages ; Editing ; Engineering and Technology ; Epidemics ; Epidemiology ; Evaluation ; Funding ; HIV ; HIV infection ; Human immunodeficiency virus ; Interviews ; Medical research ; Medicine and Health Sciences ; Methods ; Participation ; Patient compliance ; People and places ; Polls & surveys ; Prevention ; Quantitative psychology ; Research and Analysis Methods ; Reviews ; Social Sciences ; Tutu, Desmond ; Vagina ; Visualization</subject><ispartof>PloS one, 2021-05, Vol.16 (5), p.e0251823-e0251823</ispartof><rights>COPYRIGHT 2021 Public Library of Science</rights><rights>2021 Zissette et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 Zissette et al 2021 Zissette et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c618t-8e9bfb7208eb0133d449b56d0acb6725e30e0e5b88190e59c3303f3a3754f9ff3</cites><orcidid>0000-0002-9823-3675</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158999/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158999/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79342,79343</link.rule.ids></links><search><creatorcontrib>Zissette, Seth</creatorcontrib><creatorcontrib>Tolley, Elizabeth E</creatorcontrib><creatorcontrib>Martinez, Andres</creatorcontrib><creatorcontrib>Hanif, Homaira</creatorcontrib><creatorcontrib>Gill, Katherine</creatorcontrib><creatorcontrib>Mugo, Nelly</creatorcontrib><creatorcontrib>Myers, Laura</creatorcontrib><creatorcontrib>Casmir, Ednar</creatorcontrib><creatorcontrib>Duyver, Menna</creatorcontrib><creatorcontrib>Ngure, Kenneth</creatorcontrib><creatorcontrib>Doncel, Gustavo F</creatorcontrib><title>Adaptation and validation of simple tools to screen and monitor for oral PrEP adherence</title><title>PloS one</title><description>Oral, vaginal and other pre-exposure prophylaxis (PrEP) products for HIV prevention are in various stages of development. Low adherence poses a serious challenge to successful evaluation in trials. In a previous study, we developed tools to screen for general adherence and specifically monitor intravaginal ring adherence within the context of HIV prevention clinical trials. This study aimed to further validate the screening tool and to adapt and provide initial psychometric validation for an oral pill monitoring tool. We administered a cross-sectional survey between June and October 2018 at a trial site located near Cape Town, South Africa, and another in Thika, Kenya, with 193 women who had experience using daily oral pills. We fit confirmatory factor analysis models on the screening tool items to assess our previously-hypothesized subscale structure. We conducted an exploratory factor analysis of oral PrEP monitoring items to determine the underlying subscale structure. We then assessed the construct validity of each tool by comparing subscales against each other within the current sample and against our original sample, from a study conducted in four sites in South Africa, including Cape Town. The screening tool structure showed moderate evidence of construct validity. As a whole, the tool performed in a similar way to the original sample. The monitoring tool items, which were revised to assess perceptions about and experiences using daily oral PrEP, factored into five subscales that showed moderate to good reliability. Four of the five subscales had a similar structure overall to the vaginal ring monitoring tool from which they were adapted. Accurate measurement of HIV-prevention product adherence is of critical importance to the assessment of product efficacy and safety in clinical trials, and the support of safe and effective product use in non-trial settings. In this study, we provide further validation for these measures, demonstrating the screening tool's utility in additional populations and adapting the monitoring tool's utility for different HIV-prevention products.</description><subject>Acquired immune deficiency syndrome</subject><subject>Agricultural technology</subject><subject>Agriculture</subject><subject>AIDS</subject><subject>Biology and Life Sciences</subject><subject>Biomarkers</subject><subject>Clinical trials</subject><subject>Cognitive ability</subject><subject>Dental prophylaxis</subject><subject>Disease prevention</subject><subject>Drafting software</subject><subject>Drug dosages</subject><subject>Editing</subject><subject>Engineering and Technology</subject><subject>Epidemics</subject><subject>Epidemiology</subject><subject>Evaluation</subject><subject>Funding</subject><subject>HIV</subject><subject>HIV infection</subject><subject>Human immunodeficiency virus</subject><subject>Interviews</subject><subject>Medical research</subject><subject>Medicine and Health Sciences</subject><subject>Methods</subject><subject>Participation</subject><subject>Patient compliance</subject><subject>People and places</subject><subject>Polls & surveys</subject><subject>Prevention</subject><subject>Quantitative psychology</subject><subject>Research and Analysis Methods</subject><subject>Reviews</subject><subject>Social Sciences</subject><subject>Tutu, Desmond</subject><subject>Vagina</subject><subject>Visualization</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNkl-L1DAUxYso7jr6DQQLgujDjElum6YvwrCsOrCwi38fQ9rczGRJmzFpF_32ZnaqbGUfpLRpkl_OzbmcLHtOyYpCRd9e-zH0yq32vscVYSUVDB5kp7QGtuSMwMM7_yfZkxivCSlBcP44O4GCFMDL6jT7vtZqP6jB-j5Xvc5vlLP6OPUmj7bbO8wH711M3zy2AfEIdr63gw-5Sa8PyuVX4fwqV3qHAfsWn2aPjHIRn03jIvv6_vzL2cflxeWHzdn6YtlyKoalwLoxTcWIwIZQAF0UdVNyTVTb8IqVCAQJlo0QtE5j3QIQMKCgKgtTGwOL7MVRd-98lFNPomQlACsLSDYX2eZIaK-u5T7YToVf0isrbxd82EoVBts6lA3TNWFaVGBoUelSEKM0rxQmsUaxQ7V3U7Wx6VC32A_J-kx0vtPbndz6GyloKeq6TgKvJ4Hgf4wYB9nZ2KJzqkc_3t674BREcrnIXv6D3u9uorYqGbC98aluexCVa86BVXVBeaJW91Dp0djZNgXI2LQ-O_BmdiAxA_4ctmqMUW4-f_p_9vLbnH11h92hcsMuejceAhfnYHEE2-BjDGj-NpkSecj_n27IQ_7llH_4Dc6S9UE</recordid><startdate>20210527</startdate><enddate>20210527</enddate><creator>Zissette, Seth</creator><creator>Tolley, Elizabeth E</creator><creator>Martinez, Andres</creator><creator>Hanif, Homaira</creator><creator>Gill, Katherine</creator><creator>Mugo, Nelly</creator><creator>Myers, Laura</creator><creator>Casmir, Ednar</creator><creator>Duyver, Menna</creator><creator>Ngure, Kenneth</creator><creator>Doncel, Gustavo F</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-9823-3675</orcidid></search><sort><creationdate>20210527</creationdate><title>Adaptation and validation of simple tools to screen and monitor for oral PrEP adherence</title><author>Zissette, Seth ; Tolley, Elizabeth E ; Martinez, Andres ; Hanif, Homaira ; Gill, Katherine ; Mugo, Nelly ; Myers, Laura ; Casmir, Ednar ; Duyver, Menna ; Ngure, Kenneth ; Doncel, Gustavo F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c618t-8e9bfb7208eb0133d449b56d0acb6725e30e0e5b88190e59c3303f3a3754f9ff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>Agricultural technology</topic><topic>Agriculture</topic><topic>AIDS</topic><topic>Biology and Life Sciences</topic><topic>Biomarkers</topic><topic>Clinical trials</topic><topic>Cognitive ability</topic><topic>Dental prophylaxis</topic><topic>Disease prevention</topic><topic>Drafting software</topic><topic>Drug dosages</topic><topic>Editing</topic><topic>Engineering and Technology</topic><topic>Epidemics</topic><topic>Epidemiology</topic><topic>Evaluation</topic><topic>Funding</topic><topic>HIV</topic><topic>HIV infection</topic><topic>Human immunodeficiency virus</topic><topic>Interviews</topic><topic>Medical research</topic><topic>Medicine and Health Sciences</topic><topic>Methods</topic><topic>Participation</topic><topic>Patient compliance</topic><topic>People and places</topic><topic>Polls & surveys</topic><topic>Prevention</topic><topic>Quantitative psychology</topic><topic>Research and Analysis Methods</topic><topic>Reviews</topic><topic>Social Sciences</topic><topic>Tutu, Desmond</topic><topic>Vagina</topic><topic>Visualization</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zissette, Seth</creatorcontrib><creatorcontrib>Tolley, Elizabeth E</creatorcontrib><creatorcontrib>Martinez, Andres</creatorcontrib><creatorcontrib>Hanif, Homaira</creatorcontrib><creatorcontrib>Gill, Katherine</creatorcontrib><creatorcontrib>Mugo, Nelly</creatorcontrib><creatorcontrib>Myers, Laura</creatorcontrib><creatorcontrib>Casmir, Ednar</creatorcontrib><creatorcontrib>Duyver, Menna</creatorcontrib><creatorcontrib>Ngure, Kenneth</creatorcontrib><creatorcontrib>Doncel, Gustavo F</creatorcontrib><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zissette, Seth</au><au>Tolley, Elizabeth E</au><au>Martinez, Andres</au><au>Hanif, Homaira</au><au>Gill, Katherine</au><au>Mugo, Nelly</au><au>Myers, Laura</au><au>Casmir, Ednar</au><au>Duyver, Menna</au><au>Ngure, Kenneth</au><au>Doncel, Gustavo F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adaptation and validation of simple tools to screen and monitor for oral PrEP adherence</atitle><jtitle>PloS one</jtitle><date>2021-05-27</date><risdate>2021</risdate><volume>16</volume><issue>5</issue><spage>e0251823</spage><epage>e0251823</epage><pages>e0251823-e0251823</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Oral, vaginal and other pre-exposure prophylaxis (PrEP) products for HIV prevention are in various stages of development. Low adherence poses a serious challenge to successful evaluation in trials. In a previous study, we developed tools to screen for general adherence and specifically monitor intravaginal ring adherence within the context of HIV prevention clinical trials. This study aimed to further validate the screening tool and to adapt and provide initial psychometric validation for an oral pill monitoring tool. We administered a cross-sectional survey between June and October 2018 at a trial site located near Cape Town, South Africa, and another in Thika, Kenya, with 193 women who had experience using daily oral pills. We fit confirmatory factor analysis models on the screening tool items to assess our previously-hypothesized subscale structure. We conducted an exploratory factor analysis of oral PrEP monitoring items to determine the underlying subscale structure. We then assessed the construct validity of each tool by comparing subscales against each other within the current sample and against our original sample, from a study conducted in four sites in South Africa, including Cape Town. The screening tool structure showed moderate evidence of construct validity. As a whole, the tool performed in a similar way to the original sample. The monitoring tool items, which were revised to assess perceptions about and experiences using daily oral PrEP, factored into five subscales that showed moderate to good reliability. Four of the five subscales had a similar structure overall to the vaginal ring monitoring tool from which they were adapted. Accurate measurement of HIV-prevention product adherence is of critical importance to the assessment of product efficacy and safety in clinical trials, and the support of safe and effective product use in non-trial settings. In this study, we provide further validation for these measures, demonstrating the screening tool's utility in additional populations and adapting the monitoring tool's utility for different HIV-prevention products.</abstract><cop>San Francisco</cop><pub>Public Library of Science</pub><pmid>34043657</pmid><doi>10.1371/journal.pone.0251823</doi><tpages>e0251823</tpages><orcidid>https://orcid.org/0000-0002-9823-3675</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1932-6203 |
| ispartof | PloS one, 2021-05, Vol.16 (5), p.e0251823-e0251823 |
| issn | 1932-6203 1932-6203 |
| language | eng |
| recordid | cdi_plos_journals_2533254304 |
| source | DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS) |
| subjects | Acquired immune deficiency syndrome Agricultural technology Agriculture AIDS Biology and Life Sciences Biomarkers Clinical trials Cognitive ability Dental prophylaxis Disease prevention Drafting software Drug dosages Editing Engineering and Technology Epidemics Epidemiology Evaluation Funding HIV HIV infection Human immunodeficiency virus Interviews Medical research Medicine and Health Sciences Methods Participation Patient compliance People and places Polls & surveys Prevention Quantitative psychology Research and Analysis Methods Reviews Social Sciences Tutu, Desmond Vagina Visualization |
| title | Adaptation and validation of simple tools to screen and monitor for oral PrEP adherence |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T23%3A06%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adaptation%20and%20validation%20of%20simple%20tools%20to%20screen%20and%20monitor%20for%20oral%20PrEP%20adherence&rft.jtitle=PloS%20one&rft.au=Zissette,%20Seth&rft.date=2021-05-27&rft.volume=16&rft.issue=5&rft.spage=e0251823&rft.epage=e0251823&rft.pages=e0251823-e0251823&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0251823&rft_dat=%3Cgale_plos_%3EA663279416%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2533254304&rft_id=info:pmid/34043657&rft_galeid=A663279416&rft_doaj_id=oai_doaj_org_article_b2d902d873f147d580fad67ae332ba2f&rfr_iscdi=true |